{"status":"OK","data":{"advertisement":{"id":345849,"title":"Zapytanie ofertowe nr LERCAN/3/PR139387/2025-3084-262534 na zakup i dostaw\u0119 aktywnych substancji farmaceutycznych:\nCandesartan cilexetil and Lercanidipine hydrochloride Ph. Eur.e\n\n\nRequest for Quotation No. LERCAN/3/PR139387/2025-3084-262534 purchase and delivery of pharmaceutical substances \nCandesartan cilexetil, and Lercanidipine hydrochloride Ph. Eur.e","partial_offer_allowed":true,"publication_date":"2026-01-29","submission_deadline":"2026-02-05 23:59:59","planned_sign_date":"2026-02-01","supplementary_orders":null,"terms_of_contract_change":"Szczeg\u00f3\u0142y w za\u0142\u0105czniku \"Zapytanie ofertowe nr LERCAN/3/PR139387/2025-3084-262534\" paragraf XIII.\nAll details in attachment \"Request for quotation No. LERCAN/3/PR139387/2025-3084-262534\" in paragraph XIII.","created_at":"2026-01-29 09:52:19","modified_at":"2026-02-06 00:00:38","contact_persons":[{"id":5781,"forename":"Pawe\u0142","surname":"Brzezi\u0144ski","phone_number":"","email":"pawel.brzezinski@polpharma.com","created_by":null,"created_at":"2026-06-22 12:46:12","modified_at":"2026-06-22 12:46:12","modified_by":null}],"orders":[{"id":558721,"estimated_value":null,"order_items":[{"id":629496,"description":"Post\u0119powanie jest prowadzone w zwi\u0105zku z realizacj\u0105 projektu pn. \u201eOpracowanie i rozw\u00f3j innowacyjnego rozwi\u0105zania \u2013 z\u0142o\u017conego, dwusk\u0142adnikowego produktu leczniczego, ukierunkowanego na terapi\u0119 nadci\u015bnienia t\u0119tniczego\u201d w ramach programu Fundusze Europejskie dla Nowoczesnej Gospodarki 2021-2027, dzia\u0142anie \u201e\u015acie\u017cka SMART\u201d, w ramach 1 Priorytetu \u201eWsparcie dla przedsi\u0119biorc\u00f3w\u201d\nPrzedmiotem zam\u00f3wienia jest zakup i dostawa aktywnych substancji farmaceutycznych:\nCandesartan cilexetil,\n\nSzczeg\u00f3\u0142y dost\u0119pne w za\u0142\u0105czniku \"Zapytanie ofertowe Nr LERCAN/3/PR139387/2025-3084-262534\"\n\n\nThe procedure is conducted in connection with the implementation of the project entitled \"Design and development of an innovative solution \u2013 a complex, two-component medicinal product aimed at the treatment of hypertension\" under the European Funds for Modern Economy 2021-2027 program, \"SMART Pathway\" measure, under the 1st Priority \"Support for Entrepreneurs\".\nThe subject of the order is the purchase and delivery of active pharmaceutical substances:\nCandesartan cilexetil\n\nDetails available in the attachment \"Request for quotation No LERCAN/3/PR139387/2025-3084-262534\"\n\n\n","warranty_period":null,"cpv_items":[{"id":1647,"code":"24950000-8","name":"Specjalistyczne produkty chemiczne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"pomorskie","poviat":"starogardzki","commune":"Starogard Gda\u0144ski","locality":"Starogard Gda\u0144ski","created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"id":714199,"type":{"id":1,"name":"adres"},"group_uuid":"fddc113d-05a2-400e-809b-40dbc8780cf1"}],"participation_conditions":[{"id":1787241,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce dysponuje uprawnieniami niezb\u0119dnymi do prawid\u0142owej realizacji zam\u00f3wienia.\n\nThe ordering party will consider that the Bidder meets this condition if the Bidder submits a\nstatement that they have the entitlements necessary for the proper execution of the order.","type":{"id":1,"name":"Uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"28707193-16d3-4eeb-853e-cb215465f333"},{"id":1787242,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce znajduje si\u0119 w sytuacji ekonomicznej i finansowej zapewniaj\u0105cej prawid\u0142ow\u0105 realizacj\u0119 zam\u00f3wienia, w szczeg\u00f3lno\u015bci nie znajduje si\u0119 w stanie upad\u0142o\u015bci, restrukturyzacji lub likwidacji.\n\nThe ordering party will consider that the Bidder meets this condition if the Bidder submits a\nstatement that they are in an economic and financial situation that ensures proper execution of the order, in particular, they are not in a state of bankruptcy, restructuring, or liquidation.","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"8f0cd7a5-11f2-4a6d-818e-7b451d0d5a29"},{"id":1787243,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi zadeklaruje termin wa\u017cno\u015bci oferowanych produkt\u00f3w a wraz z dostaw\u0105 przedstawi certyfikaty jako\u015bci potwierdzaj\u0105ce termin wa\u017cno\u015bci produkt\u00f3w:\n\u2022 dla Candesartan cilexetil \u2013 nie kr\u00f3tszy ni\u017c 24 miesi\u0105ce od daty dostawy,\n\u2022 dla Lercanidipine hydrochloride Ph. Eur. \u2013 nie kr\u00f3tszy ni\u017c 48 miesi\u0119cy od daty dostawy.\n\n\nThe Ordering Party will consider the Bidder to have met this condition if it declares that along with the delivery will present quality certificates confirming the shelf life of the offered product:\n\u2022 for Candesartan cilexetil \u2013 no less than 24 months from the delivery date,\n\u2022 for Lercanidipine hydrochloride Ph. Eur. \u2013 no less than 48 months from the delivery date.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"362e8c6b-e08b-4fd8-b3b1-8056fc37a8dc"},{"id":1787244,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce:\na)\tposiada wiedz\u0119 i do\u015bwiadczenie w zakresie wytwarzania substancji czynnych w systemie jako\u015bci zgodnym z GMP\n\nThe Ordering Party will consider the Bidder to meet this condition if it declares that:\na) it has knowledge and experience in the production of active substances in a GMP-compliant quality system.","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"165cbd0e-e127-4fc3-8329-aeb35e914664"}],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"04feb30a-6ebc-4707-a212-8742c8809cf4"}],"evaluation_criteria":[{"id":1002867,"price_criterion":true,"description":"Liczba punkt\u00f3w (PC) w kryterium \u201eCena\u201d obliczana b\u0119dzie wed\u0142ug wzoru:\nPc=Cn/Cb*90\nPc-liczba punkt\u00f3w w kryterium \u201eCena\u201d\nCn-najni\u017csza cena netto\nCb-cena netto badanej oferty\n\nPozosta\u0142e szczeg\u00f3\u0142y w za\u0142\u0105czniku \"Zapytanie ofertowe LERCAN/3/PR139387/2025-3084-262534\"","created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"525b2b06-ad86-4053-93ce-9ce33b7f863a"},{"id":1002868,"price_criterion":false,"description":"Stosowanie system\u00f3w zarz\u0105dzania \u015brodowiskowego - szczeg\u00f3\u0142y w za\u0142\u0105czniku \"Zapytanie ofertowe nr LERCAN/3/PR139387/2025-3084-262534\".\nApplication of environmental management systems - all deatails in attachment \"Request for quotation LERCAN/3/PR139387/2025-3084-262534\".","created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"52a3622a-a9ab-4a53-8f84-fdf77928f3ea"}],"is_variant":false,"title":"Candesartan cilexetil","order_node":{"id":423450},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null},{"id":558722,"estimated_value":null,"order_items":[{"id":629497,"description":"Post\u0119powanie jest prowadzone w zwi\u0105zku z realizacj\u0105 projektu pn. \u201eOpracowanie i rozw\u00f3j innowacyjnego rozwi\u0105zania \u2013 z\u0142o\u017conego, dwusk\u0142adnikowego produktu leczniczego, ukierunkowanego na terapi\u0119 nadci\u015bnienia t\u0119tniczego\u201d w ramach programu Fundusze Europejskie dla Nowoczesnej Gospodarki 2021-2027, dzia\u0142anie \u201e\u015acie\u017cka SMART\u201d, w ramach 1 Priorytetu \u201eWsparcie dla przedsi\u0119biorc\u00f3w\u201d\nPrzedmiotem zam\u00f3wienia jest zakup i dostawa substancji farmaceutycznych:\nLercanidipine hydrochloride Ph. Eur.\n\nSzczeg\u00f3\u0142y dost\u0119pne w za\u0142\u0105czniku \"Zapytanie ofertowe Nr LERCAN/3/PR139387/2025-3084-262534\"\n\n\nThe procedure is conducted in connection with the implementation of the project entitled \"Design and development of an innovative solution \u2013 a complex, two-component medicinal product aimed at the treatment of hypertension\" under the European Funds for Modern Economy 2021-2027 program, \"SMART Pathway\" measure, under the 1st Priority \"Support for Entrepreneurs\".\nThe subject of the order is the purchase and delivery of pharmaceutical substances:\nLercanidipine hydrochloride Ph. Eur.\n\nDetails available in the attachment \"Request for quotation No LERCAN/3/PR139387/2025-3084-262534\"","warranty_period":null,"cpv_items":[{"id":1647,"code":"24950000-8","name":"Specjalistyczne produkty chemiczne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"pomorskie","poviat":"starogardzki","commune":"Starogard Gda\u0144ski","locality":"Starogard Gda\u0144ski","created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"id":714200,"type":{"id":1,"name":"adres"},"group_uuid":"7940c847-ef87-4788-afa6-6aba4974018f"}],"participation_conditions":[{"id":1787245,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce dysponuje uprawnieniami niezb\u0119dnymi do prawid\u0142owej realizacji zam\u00f3wienia.\n\nThe ordering party will consider that the Bidder meets this condition if the Bidder submits a\nstatement that they have the entitlements necessary for the proper execution of the order.","type":{"id":1,"name":"Uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"66641be2-9322-4a62-b642-c93dc441142a"},{"id":1787246,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce znajduje si\u0119 w sytuacji ekonomicznej i finansowej zapewniaj\u0105cej prawid\u0142ow\u0105 realizacj\u0119 zam\u00f3wienia, w szczeg\u00f3lno\u015bci nie znajduje si\u0119 w stanie upad\u0142o\u015bci, restrukturyzacji lub likwidacji.\n\nThe ordering party will consider that the Bidder meets this condition if the Bidder submits a\nstatement that they are in an economic and financial situation that ensures proper execution of the order, in particular, they are not in a state of bankruptcy, restructuring, or liquidation.","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"19daa93c-d871-4fe0-8960-0ccb91ef0a8a"},{"id":1787247,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi zadeklaruje termin wa\u017cno\u015bci oferowanych produkt\u00f3w a wraz z dostaw\u0105 przedstawi certyfikaty jako\u015bci potwierdzaj\u0105ce termin wa\u017cno\u015bci produkt\u00f3w:\n\u2022 dla Candesartan cilexetil \u2013 nie kr\u00f3tszy ni\u017c 24 miesi\u0105ce od daty dostawy,\n\u2022 dla Lercanidipine hydrochloride Ph. Eur. \u2013 nie kr\u00f3tszy ni\u017c 48 miesi\u0119cy od daty dostawy.\n\n\nThe Ordering Party will consider the Bidder to have met this condition if it declares that along with the delivery will present quality certificates confirming the shelf life of the offered product:\n\u2022 for Candesartan cilexetil \u2013 no less than 24 months from the delivery date,\n\u2022 for Lercanidipine hydrochloride Ph. Eur. \u2013 no less than 48 months from the delivery date.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"c2adf1cc-661f-4503-bf2c-1ebf7252003a"},{"id":1787248,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce:\na)\tposiada wiedz\u0119 i do\u015bwiadczenie w zakresie wytwarzania substancji czynnych w systemie jako\u015bci zgodnym z GMP\n\nThe Ordering Party will consider the Bidder to meet this condition if it declares that:\na) it has knowledge and experience in the production of active substances in a GMP-compliant quality system.","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"486b482c-a4ab-40e5-a766-1f49e29e9463"}],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"af58dc60-5374-4725-9fdf-896fd2b7794a"}],"evaluation_criteria":[{"id":1002869,"price_criterion":true,"description":"Liczba punkt\u00f3w (PC) w kryterium \u201eCena\u201d obliczana b\u0119dzie wed\u0142ug wzoru:\nPc=Cn/Cb*90\nPc-liczba punkt\u00f3w w kryterium \u201eCena\u201d\nCn-najni\u017csza cena netto\nCb-cena netto badanej oferty\n\nPozosta\u0142e szczeg\u00f3\u0142y w za\u0142\u0105czniku \"Zapytanie ofertowe nr LERCAN/3/PR139387/2025-3084-262534\"","created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"930fbb4c-2409-4e3a-801b-7a77b3a2fb2b"},{"id":1002870,"price_criterion":false,"description":"Stosowanie system\u00f3w zarz\u0105dzania \u015brodowiskowego - szczeg\u00f3\u0142y w za\u0142\u0105czniku \"Zapytanie ofertowe nr LERCAN/3/PR139387/2025-3084-262534\".\nApplication of environmental management systems - all deatails in attachment \"Request for quotation LERCAN/3/PR139387/2025-3084-262534\".","created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null,"group_uuid":"deb76e75-10df-4e46-9409-ac6437ed18a8"}],"is_variant":false,"title":"Lercanidipine hydrochloride Ph. Eur","order_node":{"id":423451},"created_by":null,"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 12:32:52","modified_by":null}],"created_by":{"id":3084,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Zak\u0142ady Farmaceutyczne Polpharma SA","identification_number_type":"nip","identification_number":"5920202822","address":{"country":"Polska","voivodeship":"pomorskie","poviat":"starogardzki","commune":"Starogard Gda\u0144ski","locality":"Starogard Gda\u0144ski","created_by":{"id":3084,"contact_persons":[]},"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 09:52:19","modified_by":{"id":3084,"contact_persons":[]},"id":970205,"street":"Pelpli\u0144ska","number_description":"19","postcode":"83-200"},"created_by":{"id":3084,"contact_persons":[]},"created_at":"2026-01-29 09:52:19","modified_at":"2026-01-29 09:52:19","modified_by":{"id":3084,"contact_persons":[]},"id":346809},"advertisement":{"id":262534,"number":"2026-3084-262534","publication_date":"2026-01-29","created_by":{"id":3084,"contact_persons":[]},"created_at":"2026-01-29 09:52:19","modified_at":"2026-02-06 00:00:38","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[345849],"enrollment":null,"projects":[{"id":67086,"name":"Opracowanie i rozw\u00f3j innowacyjnego rozwi\u0105zania \u2013 z\u0142o\u017conego, dwusk\u0142adnikowego produktu leczniczego, ukierunkowanego na terapi\u0119 nadci\u015bnienia t\u0119tniczego.","number":"A0ST/24","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.01-A0ST/24","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":3084,"contact_persons":[]},"created_at":"2025-12-19 08:05:38","modified_at":"2025-12-19 08:05:38","modified_by":{"id":3084,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":345849,"publication_date":"2026-01-29"},"id":2294047,"name":"Zapytanie ofertowe nr LERCAN_3_PR139387_2025-3084-262534.pdf","file":{"id":2549002,"name":"Zapytanie ofertowe nr LERCAN_3_PR139387_2025-3084-262534.pdf","created_at":"2026-01-29 12:32:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/2549002"},"group_uuid":"fe2571fe-9c94-4b50-b409-fd6643616e49"},{"origin":{"id":345849,"publication_date":"2026-01-29"},"id":2294048,"name":"Request for quotation No LERCAN_3_PR139387_2025-3084-262534.pdf","file":{"id":2549004,"name":"Request for quotation No LERCAN_3_PR139387_2025-3084-262534.pdf","created_at":"2026-01-29 12:32:44","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/2549004"},"group_uuid":"c4db7494-390a-4e52-bef5-48e55ffc3c7f"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}